By offering the combined capabilities of both organizations to each of their existing and new customers, the strategic alliance shall serve to accelerate market adoption and penetration of commercially manufactured, finished EBM implants and components. The strategic partnership will leverage Arcam’s EBM technology with DTI’s expertise in engineering and producing finished components.
“This partnership with DTI is an important strategic step for Arcam. Our EBM technology has been used for manufacturing of implants in Europe since 2007, and in the US since 2010. To date, some 30 000 orthopedic implants manufactured with EBM technology have been implanted worldwide. Through this alliance with DTI, we will now also be able to offer existing and new customers contract manufacturing capabilities and help them commercialize new product applications,” says Magnus René, CEO of Arcam.